ATYPICAL CHRONIC MYELOID LEUKEMIA
Clinical trials for ATYPICAL CHRONIC MYELOID LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new ATYPICAL CHRONIC MYELOID LEUKEMIA trials appear
Sign up with your email to follow new studies for ATYPICAL CHRONIC MYELOID LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Tailored transplants for seniors: can a simple assessment improve outcomes?
Disease control OngoingThis study looks at whether a geriatric assessment—checking thinking, mobility, mood, and nutrition—can help doctors choose the best transplant approach for people aged 60 and older with certain blood cancers. The goal is to lower the risk of serious side effects and improve qual…
Matched conditions: ATYPICAL CHRONIC MYELOID LEUKEMIA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 17, 2026 07:59 UTC
-
Could a targeted drug boost chemo for tough blood cancers?
Disease control OngoingThis study tests whether adding the experimental drug veliparib to standard chemotherapy (topotecan and carboplatin) helps people with advanced myeloproliferative disorders, acute myeloid leukemia, or chronic myelomonocytic leukemia. About 25 adults took part. The goal was to see…
Matched conditions: ATYPICAL CHRONIC MYELOID LEUKEMIA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 13, 2026 16:02 UTC